BIOSECURE Act Becomes Law

On December 18, 2025, President Trump signed the BIOSECURE Act as part of the National Defense Authorization Act. The BIOSECURE Act provides that federal agencies may not contract with an entity that, in its performance of federal contracts, uses “biotechnology equipment or services” from a “biotechnology company of concern.”

A company is considered a “biotechnology company of concern” if it appears on the annual 1260H list of Chinese military companies or is designated by the Office of Management and Budget (OMB) based on its ownership or control by the government of a foreign adversary and national security risk to the United States. OMB must issue its list of designated companies and implementation guidance by December 2026.